Navigation Links
Testosterone Therapy can improve sexual function in postmenopausal women

The addition of testosterone to hormone therapy in women after menopause has been found to enhance their sexual performance. However, it may also reduce HDL cholesterol (the “good” cholesterol) in women, according to a recent research.//

Menopause generally begins around age 40, and is characterized by decreased levels of the female sex hormones- estrogen and progesterone that preserve intactness of the vagina and uterus. In addition the hormone is also involved in the health of bones and keeping HDL at healthy levels. Changes brought by menopause can lead to side effects such as “hot flashes” and problems with mood, sleep, memory and joint stiffness.

Sexual function is also compromised in many women. The genital area can become dry and thin during or after menopause, making sexual intercourse painful and undesirable. There is an accompanying decrease in the sex drive (libido), reflected by slower sexual response in some women.

Testosterone is a natural sex hormone produced by the testis. Although it is thought of as a male hormone, women secrete small amounts of it as well. The present study involved the examination of over 1,957 patients who were given testosterone in addition to the conventional hormone replacement therapy for 6 months. The participants were required to fill questionnaires reflecting their sexual activity, libido and side effects if any.

The observed benefits and side effects included a sense of well-being, unexplained fatigue, breast cancer, mood changes, acne and increased hair growth; none were significant enough to be linked definitively to the addition of testosterone to hormone replacement therapy. If the reduction in HDL had been associated with an increase in triglycerides [fatty acids] or LDL cholesterol it would be of great concern. Testosterone has not been found to alter other coronary heart disease risk factors. The researchers have however expressed concern for potential side effects with long term testosterone usage such as voice changes, increased body and facial hair, acne and other undesirable defeminizing side-effects.

The authors do caution that adding testosterone to HT is not a panacea for sexual dysfunction in women and that a comprehensive approach is recommended. “Because of the complex nature of female sexual dysfunction it is often difficult to establish the meaningful steps in treatment,” they write. “Treatment options for sexual dysfunction include identification of correctable causes, education and counseling, and medical therpy.”
'"/>




Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching ... area, announces the launch of a new and proprietary customer relationship management (CRM) system ... physicians to help them with back or neck pain and helps to match them ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a leading provider ... care management module. Using this new feature, sleep physicians can now predict the ... continuous positive airway pressure (CPAP), oral, or other forms of sleep apnea therapy. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Ridgecrest Herbals ... encourage sustainability, innovate new strategies to reduce waste, and support renewable energy. They believe ... They look to nature to find solutions for health issues, and maintain that destroying ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: